vimarsana.com
Home
Live Updates
Artelo Biosciences Presents Positive Pre-Clinical Results of
Artelo Biosciences Presents Positive Pre-Clinical Results of
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Related Keywords
Ireland ,
Bailey Allen Hall ,
Saoirse Osullivan ,
Artelo Biosciences ,
Crescendo Communications ,
Twitter ,
International Cannabinoid Research Society ,
Nasdaq ,
Artelo Biosciences Inc ,
Exchange Commission ,
National University Of Ireland ,
Translational Sciences At Artelo Biosciences ,
Securities Exchange ,
Professor Saoirseo Sullivan ,
Vice President ,
Translational Sciences ,
Preclinical Evaluation ,
Novel Inhibitor ,
Professor Saoirse ,
Induced Peripheral Neuropathy ,
Chief Executive Officer ,
National University ,
Acid Binding Proteins ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Relations Contact ,
Politics ,
Science ,
Health ,
Business ,
Globe Newswire ,
Cancer ,
Chemotherapy ,